Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

Inclusion Criteria: * Any Fitzpatrick skin types I-VI, with effort to include minimum n = 1 for each category per site * Any races and ethnicities, with effort to include minimum n = 2 per site for whom identify as American Indian or Alaska Native, Eastern/Southeastern Asian, South Asians, Hispanic or Latino, Black or African American, Native Hawaiian or Other Pacific Islander, etc. * Subject with moderate-to-severe cheek wrinkles on the GCWS * Subject with mild-to-severe midface contour deficiencies on the MMVS * Subject with intent to undergo correction of cheek augmentation or midface contour deficiencies. * Subject with history of taking or currently taking GLP-1 receptor agonist medications such as semaglutide, liraglutide, etc. * Subject with stable Body Mass Index (BMI) within 4-6 weeks before study start. * Subject willing to maintain a stable Body Mass Index (BMI, ± 2 kg/m2) throughout the study. * Willing to maintain the current lifestyle and daily routine (e.g., diet, exercise, sleep, etc.) throughout the study. * Subject willing to be photographed at each visit. * Subject willing to abstain from any other facial plastic surgical or cosmetic procedure(s) during the duration of the study. * For female subjects of childbearing potential, she agrees to use an acceptable form of effective birth control for the duration of the study. Subjects must be willing to take a urine pregnancy test (UPT) prior to all treatments. (Females of non-childbearing potential, e.g., post…